Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

H-ras codon 12 mutation in cervical dysplasia

L Van Le1, J Stoerker, C A Rinehart

  • 1Department of Obstetrics and Gynecology, University of North Carolina, Chapel Hill.

Gynecologic Oncology
|May 1, 1993
PubMed
Summary

H-ras codon 12 mutations are not detected in early cervical dysplasia, suggesting they are not an early event in cervical cancer development. Human papillomavirus (HPV) is associated with precancerous lesions.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Clinical calculator predictive of chemotherapy benefit in stage 1A uterine papillary serous cancers.

Gynecologic oncology·2019
Same author

Rationale and study protocol for the Patient-Centered Outcome Aid (PCOA) randomized controlled trial: A personalized decision tool for newly diagnosed ovarian cancer patients.

Contemporary clinical trials·2017
Same author

The Venereal Problem in Civil Life.

Journal of the National Medical Association·2010
Same author

Chemotherapy.

NAPT bulletin·2010
Same author

Medical aspects of marriage guidance.

Lancet (London, England)·2010
Same author

Repression of the prolactin promoter: a functional consequence of the heterodimerization between Pit-1 and Pit-1 beta.

Journal of molecular endocrinology·2005

Area of Science:

  • Oncology
  • Molecular Biology
  • Virology

Background:

  • The H-ras oncogene's codon 12 mutation is linked to cervical cancer development.
  • Investigating the role of H-ras mutations in early carcinogenesis is crucial for understanding cervical cancer progression.

Purpose of the Study:

  • To determine if H-ras codon 12 mutations occur early in cervical carcinogenesis.
  • To analyze the association between H-ras mutations, human papillomavirus (HPV) infection, and cervical dysplasia stages.

Main Methods:

  • Cervical DNA from 63 normal and 72 dysplasia patients (CIN I, II, III) was analyzed.
  • HPV typing was performed using Viratype and PCR.
  • H-ras codon 12 mutations were detected using PCR amplification and MspI restriction enzyme analysis.

Related Experiment Videos

Main Results:

  • Human papillomavirus (HPV) 16 or 18 was detected in increasing prevalence with higher grades of cervical dysplasia (33% CIN I, 56% CIN II, 100% CIN III).
  • No H-ras codon 12 mutations were found in any of the analyzed cervical dysplasia samples.
  • The study found no evidence of H-ras codon 12 mutations in precancerous cervical lesions.

Conclusions:

  • HPV infection is strongly associated with cervical dysplasia, with prevalence increasing in more advanced lesions.
  • H-ras codon 12 mutations are unlikely to be an early event in the progression from cervical dysplasia to cervical carcinoma.
  • The findings suggest that other molecular mechanisms may drive early cervical carcinogenesis.